VIMPAT 200 MG TABLET
FDA nonproprietary name: lacosamide
For 30 tablets
Pharmacies pay
$588.80 filed
30 × $19.62683 per EA
CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17
Medicare
We don’t know yet
No Medicare reference price. Part D: OpenBill did not match this NDC to a usable Medicare Part D spending row. Either Part D has none for it, or the rows that share its name could not safely be tied to it (for example, they mix units, routes or release forms, or the drug is sold over the counter, which Part D does not cover). Part B: This NDC is not in the current quarter’s Medicare Part B NDC-HCPCS crosswalk, so it has no Part B payment limit.
The spread
We don’t know yet
There is no Medicare figure to compare with, so there is no spread.
Cost-plus estimate
$682.12 estimated
$588.80 + $88.32 (15%) + $5.00 fee per fill = $682.12
This is a model, not a price any pharmacy quoted. Shipping is not included. How it is worked out
OpenBill calculation · nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2026-09-23 (file of 2026-10-14, retrieved 2026-10-17)
Open the interactive card Change the quantity, type what you were charged, and see every record in full.
What it is
VIMPAT 200 MG TABLET is how the CMS NADAC file names this product. The FDA NDC Directory lists it as lacosamide, under the trade name “Vimpat”.
FDA gives its dosage form as tablet, film coated and its route as oral.
The labeler, the company named on the label, is UCB, Inc.
FDA lists no Established Pharmacologic Class for it.
The NADAC file of 2026-10-14 prices it under 2 NDCs (National Drug Codes).
NADAC classes it as a brand-name drug (rate-setting class B), and does not mark it as sold over the counter.
What pharmacies pay
Pharmacies pay $588.80 for 30 tablets (30 × $19.62683 per EA, rounded to the cent), by the CMS NADAC file of 2026-10-14; that price took effect on 2026-09-23. That is what pharmacies pay their suppliers, not what they charge you.
NADAC’s explanation code for it: 1, calculated from the most recently completed pharmacy survey.
NADAC also lists, on the row of its brand NDCs, what pharmacies pay for the generic equivalent, a different product: $0.24797 per EA filed.
CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17
What NADAC measures · Why 30 tablets · NADAC explanation codes
All 2 NDCs
- 00131-2480-35 · UCB, Inc. · $19.62683 per EA · eff. 2026-09-23 filed
- 00131-2480-60 · UCB, Inc. · $19.62683 per EA · eff. 2026-09-23 filed
Other strengths, forms and brands
14 other products in the NADAC file share the FDA nonproprietary name lacosamide with VIMPAT 200 MG TABLET.
| Product | Pharmacies pay per unit | Medicare per unit |
|---|---|---|
| LACOSAMIDE 10 MG/ML SOLUTION | $0.08288 per ML filed | We don’t know yet |
| LACOSAMIDE 50 MG TABLET | $0.11859 per EA filed | We don’t know yet |
| LACOSAMIDE 100 MG TABLET | $0.17426 per EA filed | We don’t know yet |
| LACOSAMIDE 100 MG/10 ML CUP | $0.08288 per ML filed | We don’t know yet |
| LACOSAMIDE 150 MG TABLET | $0.22128 per EA filed | We don’t know yet |
| LACOSAMIDE 200 MG TABLET | $0.24797 per EA filed | We don’t know yet |
| LACOSAMIDE 200 MG/20 ML CUP | $0.08288 per ML filed | We don’t know yet |
| MOTPOLY XR 100 MG CAPSULE | $21.43011 per EA filed | $20.10931 per EA filed |
| MOTPOLY XR 150 MG CAPSULE | $21.50185 per EA filed | $20.10931 per EA filed |
| MOTPOLY XR 200 MG CAPSULE | $21.5109 per EA filed | $20.10931 per EA filed |
| VIMPAT 10 MG/ML SOLUTION | $2.29765 per ML filed | We don’t know yet |
| VIMPAT 50 MG TABLET | $11.82165 per EA filed | We don’t know yet |
| VIMPAT 100 MG TABLET | $18.53662 per EA filed | We don’t know yet |
| VIMPAT 150 MG TABLET | $19.64607 per EA filed | We don’t know yet |
| VIMPAT 200 MG TABLET this page | $19.62683 per EA filed | We don’t know yet |
Part D is one average per brand and generic name, over every strength and form.
CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-07-01, 2026-09-23, 2026-09-30 · as of 2026-10-14 · retrieved 2026-10-17
Medicare Part D · DSD_PTD_RY26_P04_V10_DY24_BGM.csv · eff. 2024-01-01 to 2024-12-31 · as of 2026-06-25 · retrieved 2026-10-18
What Medicare paid
We don’t know yet; the card above says why.
Which Medicare figure OpenBill compares · How Part D is matched · How Part B is matched
What to ask at the counter
None of these figures is your price: what you pay depends on your pharmacy, your insurance, coupons and discounts.
- What is your cash price for 30 tablets? Is it lower than what I would pay through my insurance?
- Is a generic version available, and would it suit me? NADAC lists a generic with the same ingredient, strength and dosage form by FDA: LACOSAMIDE 200 MG TABLET. Ask your pharmacist or prescriber; do not switch on your own.
- These are questions about price, not medical advice. Do not change or stop a medicine without talking to your prescriber or pharmacist.